hotspot -WSS

hotspot

author：comprehensive 2025-09-30 23:20:23 - browse：739

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

The Food and Drug Administration on Thursday approved an Eli Lilly drug that takes a new approach to treating ulcerative colitis, a chronic inflammatory disease that can cause intense gastrointestinal pain and distress.

The therapy, dubbed Omvoh, is an antibody that blocks IL-23p19, an immune signaling molecule that plays a key role in sustaining the disease. It’s the first treatment to target this particular pathway in ulcerative colitis. The drug’s approval comes after two late-stage trials found that patients taking Omvoh showed a significant improvement in symptoms after both three months and a year compared with those given a placebo, and that the therapy had minimal side effects.

Omvoh’s list price will be $9,593 per month for intravenous delivery and $10,360 per dose injected beneath the skin. A company spokesperson told STAT that patients who have the drug covered by commercial insurance may pay as little as $5 per month for up to 30 months.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： ALS advocates say criticism of new drugs misses bigger picture

focus

WSS

Why Titanic fascinates society, still drawing tours to the wreckage

Rare Northern Lights show in US this week: Where and how to see it

Zelenskyy on how Russian invasion may end, gratitude for US aid and Putin's weakness

California man arrested in connection with serial murders of Mexican strip club workers

Tennessee woman gets emergency hysterectomy after doctors deny early abortion care

California man arrested in connection with serial murders of Mexican strip club workers

explore

hotspot

leisure time

Heart attack and stroke risk calculators need revising

What American doctors can learn from their Israeli counterparts

Tori Bowie and the unacceptable rates of Black maternal death

'Make People Better': The CRISPR babies story you probably don't know

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Titanic submersible: What a 'catastrophic implosion' means and what officials found

Heart attack and stroke risk calculators need revising

Zelenskyy on how Russian invasion may end, gratitude for US aid and Putin's weakness

Medicare details structure of new drug price negotiation program

Illumina names Agilent executive as new CEO

focus

Neutralizing antibodies against HIV shows promise in children

What American doctors can learn from their Israeli counterparts

How redistricting in 6 states could affect who controls Congress

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

'Make People Better': The CRISPR babies story you probably don't know

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

focus

hotspot

focus

focus